---
figid: PMC7969799__fcell-09-611773-g001
figtitle: 'The molecular mechanism of TRP channel-mediated pathogenesis of neurological
  disorders: (A) Alzheimer’s disease, (B) Parkinson’s disease, (C) Huntington’s disease,
  (D) Amyotrophic lateral sclerosis, and (E) epilepsy'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Saccharomyces cerevisiae
- Danio rerio
pmcid: PMC7969799
filename: fcell-09-611773-g001.jpg
figlink: pmc/articles/PMC7969799/figure/F1/
number: F1
caption: 'Schematic of the molecular mechanism of TRP channel-mediated pathogenesis
  of neurological disorders: (A) Alzheimer’s disease, (B) Parkinson’s disease, (C)
  Huntington’s disease, (D) Amyotrophic lateral sclerosis, and (E) epilepsy. In the
  figure, red arrows represent increase or up-regulation; green arrows, decrease or
  down-regulation; red thick bar, inhibition of the signaling pathway; and black arrows,
  activation of the signaling pathway. Ion channels involved in each of the neurological
  disorders and their transporting ions, channel agonists, and antagonists are also
  shown in the figure. Abbreviations: BDNF, brain-derived neurotrophic factor; ROS,
  reactive oxygen species; Aβ, beta-amyloid; PPAR, peroxisome proliferator-activated
  receptor gamma; AMPK, 5′ adenosine monophosphate-activated protein kinase; mTOR,
  mechanistic target of rapamycin; NMDAR, N-methyl-D-aspartate receptor; NAADP, Nicotinic
  acid adenine dinucleotide phosphate; PI(3,4)P2, phosphatidylinositol (3,4)-bisphosphate;
  PD, Parkinson’s disease; ER, endoplasmic reticulum; GABA, gamma-aminobutyric acid;
  DA, dopamine; ALS/FTD, amyotrophic lateral sclerosis patients with frontotemporal
  dementia; L-BMAA, L-beta-methylamino-L-alanine; IL, interleukin; TNF-α, tumor necrosis
  factor alpha; CPZ, capsazepine; IRTX, 5′-Iodoresiniferatoxin; KA, kainic acid; pPKCα,
  phospho-protein kinase C alpha; pERK1/2, phospho-extracellular signal-regulated
  kinase 1/2.'
papertitle: Functional Importance of Transient Receptor Potential (TRP) Channels in
  Neurological Disorders.
reftext: Kihwan Lee, et al. Front Cell Dev Biol. 2021;9:611773.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.5657542
figid_alias: PMC7969799__F1
figtype: Figure
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC7969799__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7969799__fcell-09-611773-g001.html
  '@type': Dataset
  description: 'Schematic of the molecular mechanism of TRP channel-mediated pathogenesis
    of neurological disorders: (A) Alzheimer’s disease, (B) Parkinson’s disease, (C)
    Huntington’s disease, (D) Amyotrophic lateral sclerosis, and (E) epilepsy. In
    the figure, red arrows represent increase or up-regulation; green arrows, decrease
    or down-regulation; red thick bar, inhibition of the signaling pathway; and black
    arrows, activation of the signaling pathway. Ion channels involved in each of
    the neurological disorders and their transporting ions, channel agonists, and
    antagonists are also shown in the figure. Abbreviations: BDNF, brain-derived neurotrophic
    factor; ROS, reactive oxygen species; Aβ, beta-amyloid; PPAR, peroxisome proliferator-activated
    receptor gamma; AMPK, 5′ adenosine monophosphate-activated protein kinase; mTOR,
    mechanistic target of rapamycin; NMDAR, N-methyl-D-aspartate receptor; NAADP,
    Nicotinic acid adenine dinucleotide phosphate; PI(3,4)P2, phosphatidylinositol
    (3,4)-bisphosphate; PD, Parkinson’s disease; ER, endoplasmic reticulum; GABA,
    gamma-aminobutyric acid; DA, dopamine; ALS/FTD, amyotrophic lateral sclerosis
    patients with frontotemporal dementia; L-BMAA, L-beta-methylamino-L-alanine; IL,
    interleukin; TNF-α, tumor necrosis factor alpha; CPZ, capsazepine; IRTX, 5′-Iodoresiniferatoxin;
    KA, kainic acid; pPKCα, phospho-protein kinase C alpha; pERK1/2, phospho-extracellular
    signal-regulated kinase 1/2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Bdnf
  - App
  - H2-Ab1
  - Mapt
  - Csnk1e
  - Mtor
  - Trpm7
  - Trpc1
  - Trpc5
  - Trpc4
  - Trpv4
  - Il18
  - Tnf
  - Il6
  - Trpc7
  - Trpm2
  - Mcoln1
  - Serpina1c
  - da
  - Opn3
  - Casp3
  - Igfals
  - Camk2a
  - Camk2b
  - Cpz
  - Pd
  - Trpv1
  - Prkaa2
  - Wfdc15b
  - Camk2d
  - BDNF
  - BDNF-AS
  - APP
  - SUCLA2
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MAPT
  - MTOR
  - TRPM7
  - TRPC1
  - TRPC5
  - TRPC4
  - TRPV4
  - IL18
  - TNF
  - IL6
  - TRPC7
  - TRPM2
  - MCOLN1
  - PI3
  - IGFALS
  - SOD1
  - CAMK2G
  - CPZ
  - TRPV1
  - bdnf
  - slc6a6b
  - mtor
  - trpm7
  - trpc1
  - trpc5a
  - trpv4
  - tnfb
  - il6
  - moto
  - cpz
  - trpv1
---
